Debulking surgery and hyperthermic intraperitoneal chemotherapy in the management of a recurrent aggressive uterine myxoid leiomyosarcoma with peritoneal dissemination

• A rare case of recurrent peritoneal sarcomatosis (PS) arising from aggressive uterine myxoid leiomyosarcoma was described. • Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) has the potential to improve outcomes in PS from uterine sarcoma. • Careful patient selection fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Inoue, Daisuke, Yamamoto, Makoto, Sugita, Genki, Kurokawa, Tetsuji, Yoshida, Yoshio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4563799/
https://www.ncbi.nlm.nih.gov/pubmed/26425725
http://dx.doi.org/10.1016/j.gore.2015.06.010
_version_ 1782389336668372992
author Inoue, Daisuke
Yamamoto, Makoto
Sugita, Genki
Kurokawa, Tetsuji
Yoshida, Yoshio
author_facet Inoue, Daisuke
Yamamoto, Makoto
Sugita, Genki
Kurokawa, Tetsuji
Yoshida, Yoshio
author_sort Inoue, Daisuke
collection PubMed
description • A rare case of recurrent peritoneal sarcomatosis (PS) arising from aggressive uterine myxoid leiomyosarcoma was described. • Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) has the potential to improve outcomes in PS from uterine sarcoma. • Careful patient selection for cytoreductive surgery with HIPEC is important to achieve better outcomes in PS.
format Online
Article
Text
id pubmed-4563799
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-45637992015-09-30 Debulking surgery and hyperthermic intraperitoneal chemotherapy in the management of a recurrent aggressive uterine myxoid leiomyosarcoma with peritoneal dissemination Inoue, Daisuke Yamamoto, Makoto Sugita, Genki Kurokawa, Tetsuji Yoshida, Yoshio Gynecol Oncol Rep Case Report • A rare case of recurrent peritoneal sarcomatosis (PS) arising from aggressive uterine myxoid leiomyosarcoma was described. • Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) has the potential to improve outcomes in PS from uterine sarcoma. • Careful patient selection for cytoreductive surgery with HIPEC is important to achieve better outcomes in PS. Elsevier 2015-07-02 /pmc/articles/PMC4563799/ /pubmed/26425725 http://dx.doi.org/10.1016/j.gore.2015.06.010 Text en © 2015 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Inoue, Daisuke
Yamamoto, Makoto
Sugita, Genki
Kurokawa, Tetsuji
Yoshida, Yoshio
Debulking surgery and hyperthermic intraperitoneal chemotherapy in the management of a recurrent aggressive uterine myxoid leiomyosarcoma with peritoneal dissemination
title Debulking surgery and hyperthermic intraperitoneal chemotherapy in the management of a recurrent aggressive uterine myxoid leiomyosarcoma with peritoneal dissemination
title_full Debulking surgery and hyperthermic intraperitoneal chemotherapy in the management of a recurrent aggressive uterine myxoid leiomyosarcoma with peritoneal dissemination
title_fullStr Debulking surgery and hyperthermic intraperitoneal chemotherapy in the management of a recurrent aggressive uterine myxoid leiomyosarcoma with peritoneal dissemination
title_full_unstemmed Debulking surgery and hyperthermic intraperitoneal chemotherapy in the management of a recurrent aggressive uterine myxoid leiomyosarcoma with peritoneal dissemination
title_short Debulking surgery and hyperthermic intraperitoneal chemotherapy in the management of a recurrent aggressive uterine myxoid leiomyosarcoma with peritoneal dissemination
title_sort debulking surgery and hyperthermic intraperitoneal chemotherapy in the management of a recurrent aggressive uterine myxoid leiomyosarcoma with peritoneal dissemination
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4563799/
https://www.ncbi.nlm.nih.gov/pubmed/26425725
http://dx.doi.org/10.1016/j.gore.2015.06.010
work_keys_str_mv AT inouedaisuke debulkingsurgeryandhyperthermicintraperitonealchemotherapyinthemanagementofarecurrentaggressiveuterinemyxoidleiomyosarcomawithperitonealdissemination
AT yamamotomakoto debulkingsurgeryandhyperthermicintraperitonealchemotherapyinthemanagementofarecurrentaggressiveuterinemyxoidleiomyosarcomawithperitonealdissemination
AT sugitagenki debulkingsurgeryandhyperthermicintraperitonealchemotherapyinthemanagementofarecurrentaggressiveuterinemyxoidleiomyosarcomawithperitonealdissemination
AT kurokawatetsuji debulkingsurgeryandhyperthermicintraperitonealchemotherapyinthemanagementofarecurrentaggressiveuterinemyxoidleiomyosarcomawithperitonealdissemination
AT yoshidayoshio debulkingsurgeryandhyperthermicintraperitonealchemotherapyinthemanagementofarecurrentaggressiveuterinemyxoidleiomyosarcomawithperitonealdissemination

Ejemplares similares